Literature DB >> 9672848

Generation of tumor-specific cytotoxic T lymphocytes and memory T cells by immunization with tumor-derived heat shock protein gp96.

S Janetzki1, N E Blachere, P K Srivastava.   

Abstract

Tumor-derived heat shock proteins have been shown previously to elicit specific prophylactic immunity to cognate tumors. Here we establish that administration of gp96 results in generation of tumor-specific cytotoxic T lymphocyte response in addition to protective immunity. In one instance, gp96 preparations are shown to elicit an immune response against a tumor, where intact tumor cells are unable to do so. Finally, our results indicate that gp96 preparations elicit a memory T cell response that is capable of being recalled.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9672848     DOI: 10.1097/00002371-199807000-00004

Source DB:  PubMed          Journal:  J Immunother        ISSN: 1524-9557            Impact factor:   4.456


  14 in total

1.  Heat shock-peptide complex vaccine as adjuvant therapy for high-risk patients with resected renal cell carcinoma.

Authors:  Oleg Shvarts; John Lam; Robert Figlin; Arie S Belldegrun
Journal:  Curr Urol Rep       Date:  2004-02       Impact factor: 3.092

2.  Essential role of CD91 in re-presentation of gp96-chaperoned peptides.

Authors:  Robert J Binder; Pramod K Srivastava
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-08       Impact factor: 11.205

3.  Heat shock protein vaccination and directed IL-2 therapy amplify tumor immunity rapidly following bone marrow transplantation in mice.

Authors:  Robert G Newman; Michael J Dee; Thomas R Malek; Eckhard R Podack; Robert B Levy
Journal:  Blood       Date:  2014-03-31       Impact factor: 22.113

4.  Natural autoantibodies against heat-shock proteins hsp70 and gp96: implications for immunotherapy using heat-shock proteins.

Authors:  A Ménoret; R Y Chandawarkar; P K Srivastava
Journal:  Immunology       Date:  2000-11       Impact factor: 7.397

5.  Immunization with chaperone-peptide complex induces low-avidity cytotoxic T lymphocytes providing transient protection against herpes simplex virus infection.

Authors:  Udayasankar Kumaraguru; Malgorzata Gierynska; Shanna Norman; Barry D Bruce; Barry T Rouse
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

6.  Inducible heat shock protein 70 expression as a potential predictive marker of metastasis in breast tumors.

Authors:  Carolina Torronteguy; Antonio Frasson; Felipe Zerwes; Erik Winnikov; Vinicius Duval da Silva; Antoine Ménoret; Cristina Bonorino
Journal:  Cell Stress Chaperones       Date:  2006       Impact factor: 3.667

7.  Antitumor activity of mixed heat shock protein/peptide vaccine and cyclophosphamide plus interleukin-12 in mice sarcoma.

Authors:  Quan-Yi Guo; Mei Yuan; Jiang Peng; Xue-Mei Cui; Ge Song; Xiang Sui; Shi-Bi Lu
Journal:  J Exp Clin Cancer Res       Date:  2011-02-26

8.  Development of a cytokine-modified allogeneic whole cell pancreatic cancer vaccine.

Authors:  Dan Laheru; Barbara Biedrzycki; Elizabeth M Jaffee
Journal:  Methods Mol Biol       Date:  2013

9.  Myeloma cell line-derived, pooled heat shock proteins as a universal vaccine for immunotherapy of multiple myeloma.

Authors:  Jianfei Qian; Sungyoul Hong; Siqing Wang; Liang Zhang; Luhong Sun; Michael Wang; Jing Yang; Larry W Kwak; Jian Hou; Qing Yi
Journal:  Blood       Date:  2009-08-04       Impact factor: 22.113

Review 10.  The allure and peril of hematopoietic stem cell transplantation: overcoming immune challenges to improve success.

Authors:  Robert G Newman; Duncan B Ross; Henry Barreras; Samantha Herretes; Eckhard R Podack; Krishna V Komanduri; Victor L Perez; Robert B Levy
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.